Preoperative High Protein vs Immunodiet in Surgical Cancer Patients

• Status: Completed
• Trial end date: 2021-03-31
• Target enrollment: 0
• Participant gender: All

Summary

Immunomodulating nutrition is supposed to reduce the number of complications and the legnth of the hospital stay during the postoperative period in patients after major gastrointestinal surgery. The aim of the study is to assess the clinical effect of immunomodulating oral nutrition in patients undergoing resection for gastrointestinal cancer in the group of well-nourished patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanley Dudrick's Memorial Hospital

Criteria

Inclusion Criteria:

• resectable GI cancer

• written consent

Exclusion Criteria:

• inoperable GI cancer

• known allergy to the drug